ARTICLES BY THIS AUTHOR
- 2/10/2020
Sun Pharma rolls out Absorica LD
Sun Pharma's Absorica LD features a special formulation of active ingredient isotretinoin meant to optimize absorption at a 20% lower dose. - 2/10/2020
Problem solvers: Tech, automation makers aim to enable clinical efforts
Pharmacy technology and automation companies are seeing more industry disruption than ever, and in response, they're ratcheting up their products and services to help pharmacies succeed. - 2/10/2020
HDA taps AAM's Chip Davis as CEO
Chester "Chip" Davis' is leaving AAM, to serve as HDA president and CEO; Jeffrey Francer, AAM's senior vice president and general counsel, will serve as interim AAM CEO. - 2/10/2020
Aurobindo gets FDA nod for 3 generics
Oxycodone hydrochloride oral solution, methotrexate tablets, and trazodone hydrochloride tablets have a market value of roughly $33 million, $97.7 million and $123 million, respectively for the 12 months ended December 2019. - 2/10/2020
Kinney Drugs campaign aims to surpass 2019 success
Kinney Drugs' fundraising efforts for the American Heart Association earned it recognition as the organization's No. 2 fundraiser in the country. - 2/7/2020
PQA retires 6 performance measures, endorses 3 new ones
The Pharmacy Quality Alliance has endorsed three new pharmacy performance measures that evaluate adherence for medication treatment of hypertension, cholesterol and HIV. - 2/7/2020
NCPA sets 2020 Pharmacy Ownership Workshop dates
The Pharmacy Ownership Workshop, sponsored by McKesson, will cover financing, marketing, business development, and profitable merchandising ideas. - 2/7/2020
FIP releases coronavirus guidelines for pharmacists
The International Pharmaceutical Federation guidelines will be downloadable in the six official United Nations languages along with other resources on the FIP website. - 2/7/2020
Dr. Reddy’s debuts generic Syprine
Dr. Reddy's generic Syprine offers an alternative that can be stored at room temperature throughout its 24-month shelf life. - 2/6/2020
Cardinal Health posts 5% revenue growth in Q2
Cardinal Health's second-quarter revenue for the pharmaceutical segment was $35.7 billion, a hike of 6% from the same period last year.